Novonesis A/s Class B · OMXCOP:NSIS_B
Novonesis A/s Class B — FY 2024 Earnings Presentation
14 slides from Novonesis A/s Class B's earnings presentation, Feb 26, 2025
Slide 1: FY 2024 Conference Call
FY 2024 Conference Call
Slide 2: Forward-looking statement
Forward-looking statement Disclaimer This announcement includes forward-looking statements. Such forward-looking statements are subject to a number of risks and uncertainties, many of which are beyond the control of the combined group and all of which are based on the combined group's current belief
Slide 3: Full year 2024 organic sales growth of 8% (7% in Q4). Strong 2025 outlook.
Full year 2024 organic sales growth of 8% (7% in Sales and organic sales growth y/y 45% 55% Q4). Strong 2025 outlook. Food & Health Biosolutions Planetary Health Sales performance 12M 2024 EURm Biosolutions • Organic sales growth (OSG) of 8% +8% • Growth driven by volume (~6%) and supported by prici
Slide 4: Food & Health Biosolutions
Human Health Sales and organic sales growth, 26% Food & Health Biosolutions y/y Food & Health Biosolutions 74% EURm +7% Food & Beverages OSG Performance 12M 2024 • Organic sales growth of 7% +7% OSG • Growth supported by both Food & Beverages and Human 1,720.8 1,770.9 Health 424.7 433.8 • Adjusted E
Slide 5: Food & Health Biosolutions: Food & Beverages
Sales and organic sales growth Food & Health Biosolutions: Food & Beverages y/y Food & Beverages EURm +8% OSG Sales performance 12M 2024 +6% • Organic sales growth of 8% OSG 1,281.1 1,310.2 • Strong growth in Dairy and solid performance across subareas • Innovation and penetration key drivers of gro
Slide 6: Food & Health Biosolutions: Human Health
Sales and organic sales growth Human Health y/y Food & Health Biosolutions: Human Health EURm +5% OSG Sales performance 12M 2024 +10% • Organic sales growth of 5% OSG 439.7 460.7 • Strong sales of Advanced Protein Solutions • Growth impacted by strong comparable and timing in HMO and 104.3 115.1 Die
Slide 7: Planetary Health Biosolutions
Household Care Sales and organic sales growth 35% Planetary Health Biosolutions y/y Planetary Health Biosolutions 65% EURm Agriculture, +9% Energy & Tech OSG Performance 12M 2024 • Organic sales growth of 9% +7% OSG • Growth driven by Household Care, supported by Agriculture, 2,023.0 2,174.6 Energy
Slide 8: Planetary Health Biosolutions: Household Care
Sales and organic sales growth Household Care y/y Planetary Health Biosolutions: Household Care EURm Sales performance 12M 2024 +13% OSG • Organic growth of 13%, driven by increased penetration, +8% innovation, and pricing OSG 685.2 767.7 • Underlying end-market volume growth supportive, especially
Slide 9: Planetary Health Biosolutions: Agriculture, Energy & Tech
Sales and organic sales growth Agriculture, Energy & Tech y/y Planetary Health Biosolutions: Agriculture, Energy & Tech EURm +6% OSG Sales performance 12M 2024 • Organic growth of 6%, driven by double-digit growth in Energy, +6% OSG supported by growth in Tech and Agriculture 1,337.8 1,406.9 • Growt
Slide 10: Financial results 2024
Financial results 2024 – 8% organic sales growth and 36.1% adjusted EBITDA margin – Strong free cash flow generation with positive one-off in H1. – Dividend proposed at DKK 4.20 (EUR ~0.56) per share – Total dividend payout for 2024 on par with 2023 – CAPEX/sales at 9.3% – NIBD/EBITDA at 1.4x 2024 2
Slide 11: Outlook 2025
Outlook 2025 • Organic sales growth of 5-8% • 4-7 % volume • ~ 1 % price • ~ 1 % sales synergies • ~ (1) % exiting certain countries • Organic sales growth of 6-9% excl. exiting certain countries • Adjusted EBITDA margin between 37 and 38% Outlook 2025¹ Organic sales growth 5-8% (6-9% excl. exit) Ad
Slide 12: Summary
Summary • Strong broad-based 2024 performance • Strong 2025 sales outlook of 5-8% • Adj. EBITDA margin outlook between 37-38% including significant growth re- investments • Investing and prioritizing to drive growth 12
Slide 13: val
val a ® ( 8 ie) tg
Slide 14: Organic sales performance by region
Organic sales performance by region North America Developed markets 12M y/y: +5% 12M y/y: +6% Europe, the Middle East & Africa 12M y/y: +8% 65% 33% of sales of sales 36% of sales Asia Pacific Latin America 12M y/y: +10% Emerging markets 12M y/y: +15% 12M y/y: +12% 12% 19% 35% of sales of sales of sa